Evidence map›Paper›PMID 19156553›Full record

ArticleAutoimmunity2009

Lupus-prone MRL/faslpr/lpr mice display increased AID expression and extensive DNA lesions, comprising deletions and insertions, in the immunoglobulin locus: concurrent upregulation of somatic hypermutation and class switch DNA recombination.

Hong Zan, Jinsong Zhang, Sona Ardeshna, Zhenming Xu, Seok-Rae Park, Paolo Casali

Open access · greenAbstract read
In one paragraph

Article in Autoimmunity, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Epigenetics of the antibody and autoantibody response.Current opinion in immunology · 2020
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. MicroRNAs in lupus.Autoimmunity · 2014
    Review
  13. TSPAN33 is a novel marker of activated and malignant B cells.Clinical immunology (Orlando, Fla.) · 2013
    Article
  14. Epigenetics of the antibody response.Trends in immunology · 2013
    Review
  15. Review
  16. Review
  17. Article
  18. Gonadal steroids and humoral immunity.Nature reviews. Endocrinology · 2013
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Hong ZanCenter for Immunology, School of Medicine and School of Biological Sciences, University of California, Irvine, CA 92697-4120, USA.
Jinsong Zhang
Sona Ardeshna
Zhenming Xu
Seok-Rae Park
Paolo Casali
University of California, Irvine · US

Funding

Somatic hypermutation and class switching in autoimmunityR01AI079705 · NIAID · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI CASALI, PAOLO · 2010 to 2019
$4.1M
Immunoglobulin class switch DNA recombinationR01AI045011 · NIAID · WEILL MEDICAL COLLEGE OF CORNELL UNIV · PI CASALI, PAOLO · 2000 to 2011
$3.8M
Immunology Research Training ProgramT32AI060573 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI PEARLMAN, ERIC · 2005 to 2020
$1.9M
Immunoglobulin class switch DNA recombinationR56AI045011 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI CASALI, PAOLO · 2012 to 2012
$523k
Molecular mechanisms in the generation of autoantibodies and lupusR56AI079705 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI CASALI, PAOLO · 2008 to 2008
$381k
NIAID NIH HHS AI045011NIAID NIH HHS AI 060573NIAID NIH HHS AI 079705NIAID NIH HHS R01 AI045011NIAID NIH HHS R01 AI079705NIAID NIH HHS R56 AI045011NIAID NIH HHS R56 AI079705NIAID NIH HHS T32 AI060573
6 · The paper itself

Abstract

Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by the production of an array of pathogenic autoantibodies, including high-affinity anti-dsDNA IgG antibodies. These autoantibodies are mutated and class-switched, mainly to IgG, indicating that immunoglobulin (Ig) gene somatic hypermutation (SHM) and class switch DNA recombination (CSR) are important in their generation. Lupus-prone MRL/fas(lpr/lpr) mice develop a systemic autoimmune syndrome that shares many features with human SLE. We found that Ig genes were heavily mutated in MRL/fas(lpr/lpr) mice and contained long stretches of DNA deletions and insertions. The spectrum of mutations in MRL/fas(lpr/lpr) B cells was significantly altered, including increased dG/dC transitions, increased targeting of the RGYW/WRCY mutational hotspot and the WGCW AID-targeting hotspot. We also showed that MRL/fas(lpr/lpr) greatly upregulated CSR, particularly to IgG2a and IgA in B cells of the spleen, lymph nodes and Peyer's patches. In MRL/fas(lpr/lpr) mice, the significant upregulation of SHM and CSR was associated with increased expression of activation-induced cytidine deaminase (AID), which mediates DNA lesion, the first step in SHM and CSR, and translesion DNA synthesis (TLS) polymerase (pol) theta, pol eta and pol zeta, which are involved in DNA synthesis/repair process associated with SHM and, possibly, CSR. Thus, in lupus-prone MRL/fas(lpr/lpr) mice, SHM and CSR are upregulated, as a result of enhanced AID expression and, therefore, DNA lesions, and dysregulated DNA repair factors, including TLS polymerases, which are involved in the repair process of AID-mediated DNA lesions.

Indexed as

DNA BreaksAICDA (Activation-Induced Cytidine Deaminase)AnimalsBase SequenceCytidine DeaminaseImmunoglobulin Class SwitchingLupus Erythematosus, SystemicLymph NodesMiceMice, Inbred C57BLMice, Inbred MRL lprMolecular Sequence DataMutagenesis, InsertionalPeyer's PatchesPoint MutationRecombination, GeneticAICDA (Activation-Induced Cytidine Deaminase)Cytidine Deaminase

Identifiers

PMID19156553
PMCPMC3140875
OpenAlexW2161259165

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.